Murat Iskar
Murat Iskar
DKFZ, Germany
Verified email at
Cited by
Cited by
Cell type-specific nuclear pores: a case in point for context-dependent stoichiometry of molecular machines
A Ori, N Banterle, M Iskar, A Andrés-Pons, C Escher, HK Bui, L Sparks, ...
Molecular Systems Biology 9 (1), 2013
Pan-cancer analysis of whole genomes
I The, TPCA of Whole, Genomes Consortium
Nature 578 (7793), 82, 2020
Prediction of drug combinations by integrating molecular and pharmacological data
XM Zhao, M Iskar, G Zeller, M Kuhn, V Van Noort, P Bork
PLoS Comput Biol 7 (12), e1002323, 2011
Drug-induced regulation of target expression
M Iskar, M Campillos, M Kuhn, LJ Jensen, V Van Noort, P Bork
PLoS Comput Biol 6 (9), e1000925, 2010
Tumor-derived exosomes modulate PD-L1 expression in monocytes
F Haderk, R Schulz, M Iskar, LL Cid, T Worst, KV Willmund, A Schulz, ...
Science immunology 2 (13), 2017
Characterization of drug‐induced transcriptional modules: towards drug repositioning and functional understanding
M Iskar, G Zeller, P Blattmann, M Campillos, M Kuhn, KH Kaminska, ...
Molecular systems biology 9 (1), 662, 2013
Luminal signalling links cell communication to tissue architecture during organogenesis
S Durdu, M Iskar, C Revenu, N Schieber, A Kunze, P Bork, Y Schwab, ...
Nature 515 (7525), 120-124, 2014
Drug discovery in the age of systems biology: the rise of computational approaches for data integration
M Iskar*, G Zeller*, XM Zhao, V van Noort, P Bork
Current opinion in biotechnology 23 (4), 609-616, 2012
Integrated transcriptome and proteome analyses reveal organ-specific proteome deterioration in old rats
A Ori, BH Toyama, MS Harris, T Bock, M Iskar, P Bork, NT Ingolia, ...
Cell Systems 1 (3), 224-237, 2015
Network neighbors of drug targets contribute to drug side-effect similarity
L Brouwers, M Iskar, G Zeller, V Van Noort, P Bork
PloS one 6 (7), e22187, 2011
Spatiotemporal variation of mammalian protein complex stoichiometries
A Ori*, M Iskar*, K Buczak, P Kastritis, L Parca, A Andrés-Pons, S Singer, ...
Genome biology 17 (1), 1, 2016
Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling
V van Noort*, S Schölch*, M Iskar*, G Zeller, K Ostertag, C Schweitzer, ...
Cancer research 74 (20), 5690-5699, 2014
DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data
C Pacini, F Iorio, E Gonçalves, M Iskar, T Klabunde, P Bork, ...
Bioinformatics 29 (1), 132-134, 2013
The landscape of viral associations in human cancers
M Zapatka*, I Borozan*, DS Brewer*, M Iskar*, A Grundhoff, M Alawi, ...
Nature Genetics, 1-12, 2020
Histone deacetylase inhibitors (HDACi) cause the selective depletion of bromodomain containing proteins (BCPs)
MT Mackmull, M Iskar, L Parca, S Singer, P Bork, A Ori, M Beck
Molecular & Cellular Proteomics 14 (5), 1350-1360, 2015
The endosomal transcriptional regulator RNF11 integrates degradation and transport of EGFR
S Scharaw, M Iskar, A Ori, G Boncompain, V Laketa, I Poser, E Lundberg, ...
Journal of Cell Biology 215 (4), 543-558, 2016
Identification and analyses of extra-cranial and cranial rhabdoid tumor molecular subgroups reveal tumors with cytotoxic T cell infiltration
HJE Chun, PD Johann, K Milne, M Zapatka, A Buellesbach, N Ishaque, ...
Cell reports 29 (8), 2338-2354. e7, 2019
Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks
JP Mallm*, M Iskar*, N Ishaque*, LC Klett, SJ Kugler, JM Muino, VB Teif, ...
Molecular systems biology 15 (5), 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations
E Pfaff, C Aichmüller, M Sill, D Stichel, M Snuderl, MA Karajannis, ...
Acta neuropathologica 139 (2), 243-257, 2020
Quantitative proteome landscape of the NCI-60 cancer cell lines
T Guo, A Luna, VN Rajapakse, CC Koh, Z Wu, W Liu, Y Sun, H Gao, ...
Iscience 21, 664-680, 2019
The system can't perform the operation now. Try again later.
Articles 1–20